GNPX

Genprex Inc

• TipRanks·05/14 16:54

  Genprex collaborators present positive preclinical data of GPX-002 in diabetes

• TipRanks·05/14 12:31

  Genprex Announces Positive Preclinical Data for Diabetes Gene Therapy

• Benzinga·05/14 12:06

  Genprex Showcases Positive Preclinical Data On Its Diabetes Gene Therapy Drug Candidate At 2026 American Society Of Gene And Cell Therapy Annual Meeting

• PR Newswire·05/14 12:00

  Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting

• Benzinga·05/13 21:36

  Genprex Q1 EPS $(0.64) Up From $(13.00) YoY

• PUBT·05/13 20:36

  Genprex Q1 net loss widens 13% to $4.46 million year over year

• Benzinga·05/06 09:58

  Top 3 Health Care Stocks That Are Set To Fly In Q2

• TipRanks·04/30 17:03

  Genprex receives patent grant from The Israel Patent Office

• TipRanks·04/30 13:35

  Genprex Expands Reqorsa Cancer Therapy Patent Protection in Israel

• Benzinga·04/30 12:08

  Israel Patent Office Grants Genprex Patent Covering Use Of Reqorsa Gene Therapy In Combination With PD-1 Antibodies For Treatment Of Cancer

• PUBT·04/30 12:01

  Genprex says Israel grants patent for Reqorsa plus PD-1 antibody cancer treatment combo

• PR Newswire·04/30 12:00

  Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer

• TipRanks·04/28 11:29

  Genprex Highlights Promising Preclinical Data for Diabetes Gene Therapy

• PUBT·04/28 11:22

  Genprex collaborators present positive preclinical diabetes gene therapy data at ASGCT meeting

• PUBT·04/28 11:04

  Genprex says diabetes gene therapy reverses hyperglycemia in preclinical Type 2 models